These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
401 related articles for article (PubMed ID: 7504119)
1. Disturbance of keratin homeostasis in griseofulvin-intoxicated mouse liver. Hutter H; Zatloukal K; Winter G; Stumptner C; Denk H Lab Invest; 1993 Nov; 69(5):576-82. PubMed ID: 7504119 [TBL] [Abstract][Full Text] [Related]
2. Posttranslational events involved in griseofulvin-induced keratin cytoskeleton alterations. Salmhofer H; Rainer I; Zatloukal K; Denk H Hepatology; 1994 Sep; 20(3):731-40. PubMed ID: 7521318 [TBL] [Abstract][Full Text] [Related]
3. Modifications in cytokeratin and actin in cultured liver cells derived from griseofulvin-fed mice. Cadrin M; Anderson NM; Aasheim LH; Kawahara H; Franks DJ; French SW Lab Invest; 1995 Apr; 72(4):453-60. PubMed ID: 7536860 [TBL] [Abstract][Full Text] [Related]
4. Experimental Mallory body formation is accompanied by modulation of the expression of multidrug-resistance genes and their products. Preisegger KH; Stumptner C; Riegelnegg D; Brown PC; Silverman JA; Thorgeirsson SS; Denk H Hepatology; 1996 Jul; 24(1):248-52. PubMed ID: 8707270 [TBL] [Abstract][Full Text] [Related]
5. Modulation of protein composition of nuclear lamina. Reduction of lamins B1 and B2 in livers of griseofulvin-treated mice. Zatloukal K; Denk H; Spurej G; Hutter H Lab Invest; 1992 May; 66(5):589-97. PubMed ID: 1573853 [TBL] [Abstract][Full Text] [Related]
6. Synthesis of Mallory body, intermediate filament, and microfilament proteins in liver cell primary cultures. An electron microscopic autoradiography assay. Kachi K; Cadrin M; French SW Lab Invest; 1993 Jan; 68(1):71-81. PubMed ID: 7678660 [TBL] [Abstract][Full Text] [Related]
7. Ubiquitin is present on the cytokeratin intermediate filaments and Mallory bodies of hepatocytes. Ohta M; Marceau N; Perry G; Manetto V; Gambetti P; Autilio-Gambetti L; Metuzals J; Kawahara H; Cadrin M; French SW Lab Invest; 1988 Dec; 59(6):848-56. PubMed ID: 2462130 [TBL] [Abstract][Full Text] [Related]
8. Fate of Mallory body-containing hepatocytes: disappearance of Mallory bodies and restoration of the hepatocytic intermediate filament cytoskeleton after drug withdrawal in the griseofulvin-treated mouse. Zatloukal K; Spurej G; Rainer I; Lackinger E; Denk H Hepatology; 1990 Apr; 11(4):652-61. PubMed ID: 1691733 [TBL] [Abstract][Full Text] [Related]
9. Excretory function in cultured hepatocytes from griseofulvin-treated mice. Kawahara H; Marceau N; French SW Lab Invest; 1989 Dec; 61(6):609-22. PubMed ID: 2481150 [TBL] [Abstract][Full Text] [Related]
10. Relationship of Mallory bodies to the cytoskeleton of hepatocytes in griseofulvin-treated mice. Irie T; Benson NC; French SW Lab Invest; 1982 Oct; 47(4):336-45. PubMed ID: 6889660 [TBL] [Abstract][Full Text] [Related]
11. Ultrastructural, biochemical, and immunologic characterization of Mallory bodies in livers of griseofulvin-treated mice. Fimbriated rods of filaments containing prekeratin-like polypeptides. Franke WW; Denk H; Schmid E; Osborn M; Weber K Lab Invest; 1979 Feb; 40(2):207-20. PubMed ID: 219290 [TBL] [Abstract][Full Text] [Related]
12. Relationship of Mallory bodies to intermediate filaments in hepatocytes. A scanning electron microscopy study. Okanoue T; Ohta M; Ou O; Kachi K; Kagawa K; Yuki T; Okuno T; Takino T; French SW Lab Invest; 1985 Nov; 53(5):534-40. PubMed ID: 2414564 [TBL] [Abstract][Full Text] [Related]
13. Electron microscopic study of the in vitro calcium-dependent degradation of Mallory bodies and intermediate filaments in hepatocytes. Irie T; Benson NC; French SW Lab Invest; 1984 Mar; 50(3):303-12. PubMed ID: 6199585 [TBL] [Abstract][Full Text] [Related]
14. Sequence of events in the assembly of Mallory body components in mouse liver: clues to the pathogenesis and significance of Mallory body formation. Stumptner C; Fuchsbichler A; Lehner M; Zatloukal K; Denk H J Hepatol; 2001 May; 34(5):665-75. PubMed ID: 11434612 [TBL] [Abstract][Full Text] [Related]
15. Mallory bodies in hepatomas and hyperplastic nodules: in vitro and in vivo studies. Cadrin M; Kawahara H; Ohta M; Katsuma Y; Marceau N; French SW Prog Clin Biol Res; 1990; 331():231-48. PubMed ID: 1690432 [No Abstract] [Full Text] [Related]
16. Rearrangement of the hepatocyte cytoskeleton after toxic damage: involution, dispersal and peripheral accumulation of Mallory body material after drug withdrawal. Denk H; Franke WW Eur J Cell Biol; 1981 Feb; 23(2):241-9. PubMed ID: 7193580 [TBL] [Abstract][Full Text] [Related]
17. High molecular weight components are main constituents of Mallory bodies isolated with a fluorescence activated cell sorter. Zatloukal K; Böck G; Rainer I; Denk H; Weber K Lab Invest; 1991 Feb; 64(2):200-6. PubMed ID: 1705301 [TBL] [Abstract][Full Text] [Related]
18. Changes of cytokeratin filament organization in human and murine Mallory body-containing livers as revealed by a panel of monoclonal antibodies. Preisegger KH; Zatloukal K; Spurej G; Denk H Liver; 1991 Oct; 11(5):300-9. PubMed ID: 1720496 [TBL] [Abstract][Full Text] [Related]
19. Novel insights into changes in biochemical properties of keratins 8 and 18 in griseofulvin-induced toxic liver injury. Fortier AM; Riopel K; Désaulniers M; Cadrin M Exp Mol Pathol; 2010 Oct; 89(2):117-25. PubMed ID: 20643122 [TBL] [Abstract][Full Text] [Related]
20. Site-specificity of ethanol-induced dephosphorylation of rat hepatocyte keratins 8 and 18: A 31P NMR study. Eckert BS; Yeagle PL Cell Motil Cytoskeleton; 1996; 33(1):30-7. PubMed ID: 8824732 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]